Miguel A. Lezama-Salazar
Mexico City, DIF, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Molecular characterization of human respiratory syncytial virus in Mexico (season 2023-2024) through whole-genome sequencing.
Journal: Scientific reports
Published: February 06, 2025
Assessment of the impact of COVID-19 on tuberculosis care at a tertiary hospital: integrating lessons from COVID-19 learned.
Journal: Frontiers in public health
Published: October 04, 2024
Comparison between the persistence of post COVID-19 symptoms on critical patients requiring invasive mechanical ventilation and non-critical patients.
Journal: PloS one
Published: September 06, 2021
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: July 29, 2020
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond.
Journal: Pulmonology
Published: October 17, 2017
Classifying new anti-tuberculosis drugs: rationale and future perspectives.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: October 05, 2016
Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.
Journal: Archivos de bronconeumologia
Published: August 03, 2016
Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data.
Journal: Revista portuguesa de pneumologia
Published: July 26, 2016
Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection.
Journal: Mucosal immunology
Published: June 24, 2016
Last Updated: 09/26/2026